- Report
- November 2025
- 187 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 180 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 193 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 189 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 185 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 184 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 181 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 198 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 189 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 187 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 194 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 188 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 186 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 193 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 186 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 197 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 192 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 198 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 183 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 187 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP

Cell therapy manufacturing is a biotechnology process that involves the production of cells for therapeutic use. This process involves the isolation, expansion, and differentiation of cells from a variety of sources, such as stem cells, primary cells, and cell lines. The cells are then used to treat a variety of diseases, including cancer, autoimmune diseases, and genetic disorders. Cell therapy manufacturing is a rapidly growing field, with new technologies and techniques being developed to improve the efficiency and safety of the process.
Cell therapy manufacturing is a complex process that requires specialized equipment and expertise. It involves the use of a variety of techniques, such as cell culture, gene editing, and cell sorting. The process also requires the use of specialized reagents and media to ensure the quality and safety of the cells.
Companies in the cell therapy manufacturing market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, GE Healthcare, and Sartorius AG. Show Less Read more